![Harold Fleming](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/05/2026
Harold Edward Fleming is currently Independent Director at CRISPR Therapeutics AG since 2021, Director at Komodo Health, Inc. since 2021, Director-Visitors Board at Vanderbilt School of Medicine Basic Sciences, Independent Director at Upstream Bio, Inc. since 2023, Independent Non-Executive Director at Sionna Therapeutics, Inc. since 2024, Director at Sudo Biosciences, Inc., Director at Egnite, Inc., and Executive Vice President at Enavate Sciences since 2022.
Formerly, Senior Partner at Mckinsey & Co., Inc. (California) from 1997 to 2022.
Education includes undergraduate degree from Harvard University and doctorate from Vanderbilt University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
UPSTREAM BIO, INC. -.--% | 09/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| 05/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 17/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CRISPR THERAPEUTICS AG | Direttore/Membro del Consiglio | 10/06/2021 |
| UPSTREAM BIO, INC. | Direttore/Membro del Consiglio | 08/06/2023 |
| SIONNA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/03/2024 |
Komodo Health, Inc.
 Komodo Health, Inc. Packaged SoftwareTechnology Services Provides AI-powered healthcare intelligence platform that leverages real-world patient data and AI-powered analytics to deliver insights that improve patient outcomes and healthcare system efficiency | Direttore/Membro del Consiglio | 30/11/2021 |
Vanderbilt School of Medicine Basic Sciences
 Vanderbilt School of Medicine Basic Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Direttore/Membro del Consiglio | - |
Enavate Sciences
 Enavate Sciences Financial ConglomeratesFinance Invests and supports therapeutic & enabling technology companies | Corporate Officer/Principal | 01/11/2022 |
Sudo Biosciences, Inc.
 Sudo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that designs and develops medicines that target the tyrosine kinase | Direttore/Membro del Consiglio | - |
Egnite, Inc.
 Egnite, Inc. Packaged SoftwareTechnology Services Provides artificial intelligence and big data analytics solutions that help to close gaps that can cause under treatment in structural heart disease | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
Mckinsey & Co., Inc. (California)
 Mckinsey & Co., Inc. (California) Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Corporate Officer/Principal | 01/08/2022 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Komodo Health, Inc.
Komodo Health, Inc. Packaged SoftwareTechnology Services Provides AI-powered healthcare intelligence platform that leverages real-world patient data and AI-powered analytics to deliver insights that improve patient outcomes and healthcare system efficiency | Technology Services |
Mckinsey & Co., Inc. (California)
Mckinsey & Co., Inc. (California) Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for CF and rare diseases | Health Technology |
Sudo Biosciences, Inc.
Sudo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that designs and develops medicines that target the tyrosine kinase | Health Technology |
Egnite, Inc.
Egnite, Inc. Packaged SoftwareTechnology Services Provides artificial intelligence and big data analytics solutions that help to close gaps that can cause under treatment in structural heart disease | Technology Services |
Vanderbilt School of Medicine Basic Sciences
Vanderbilt School of Medicine Basic Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enavate Sciences
Enavate Sciences Financial ConglomeratesFinance Invests and supports therapeutic & enabling technology companies | Finance |
Upstream Bio, Inc.
 Upstream Bio, Inc. BiotechnologyHealth Technology Engages in developing treatments for inflammatory diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
